A novel inhibitor of human telomerase derived from 10H-indolo[3,2-b]quinoline
- 5 September 2000
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 10 (18), 2063-2066
- https://doi.org/10.1016/s0960-894x(00)00378-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Molecular Modeling Studies on G-Quadruplex Complexes of Telomerase Inhibitors: Structure−Activity RelationshipsJournal of Medicinal Chemistry, 1999
- Inhibition of telomerase limits the growth of human cancer cellsNature Medicine, 1999
- G-quadruplex DNA: A target for drug designNature Medicine, 1998
- NMR-Based Model of a Telomerase-Inhibiting Compound Bound to G-Quadruplex DNABiochemistry, 1998
- Ethnobotanical-Directed Discovery of the Antihyperglycemic Properties of Cryptolepine: Its Isolation from Cryptolepis sanguinolenta, Synthesis, and in Vitro and in Vivo ActivitiesJournal of Medicinal Chemistry, 1998
- In vitro and in vivo antimalarial activity of cryptolepine, a plant‐derived indoloquinolinePhytotherapy Research, 1995
- Role of the Endothelium and Cyclic GMP in Renal Vasodilator Responses to Cryptolepine in RatsJournal of Cardiovascular Pharmacology, 1994
- Cryptospirolepine, a Unique Spiro-nonacyclic Alkaloid Isolated from Cryptolepis sanguinolentaJournal of Natural Products, 1993
- Structure and function of telomeresNature, 1991
- Studies on CryptolepinePlanta Medica, 1981